Access to Medicines in Developing Countries: Ethical Demands and Moral Economy

Developing World Bioethics 14 (2):ii-viii (2014)
  Copy   BIBTEX

Abstract

The global health crisis in non‐communicable diseases reveals a deep global health inequity that lies at the heart of global justice concerns. Mirroring the HIV/AIDS epidemic, NCDs bring into stark relief once more the human consequences of trade policies that reinforce global inequities in treatment access. Recognising distributive justice issues in access to medicines for their populations, World Trade Organisation members confirmed the primacy of access to medicines for all in trade and public health in the landmark Doha Declaration on the TRIPS Agreement and Public Health of 2001

Categories

Keywords

Reprint years

DOI

10.1111/dewb.12066

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,829

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Access to Medicines and Distributive Justice: Breaching Doha's Ethical Threshold.Rachel Kiddell-Monroe - 2014 - Developing World Bioethics 14 (2):59-66.
Access to Medicines in Developing Countries: Ethical Demands and Moral Economy.Maurice Cassier & Marilena Correa - 2014 - Developing World Bioethics 14 (2):ii-viii.
Patents and access to drugs in developing countries: An ethical analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58–75.
Improving access to essential medicines: How health concerns can be prioritised in the global governance system.Devi Sridhar - 2008 - Public Health Ethics 1 (2):83-88.
Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.
Basic Survival Needs and Access to Medicines – Coming to Grips with TRIPS: Conversion + Calculation.Rudolf V. Van Puymbroeck - 2010 - Journal of Law, Medicine and Ethics 38 (3):520-549.
The Right to Health and Medicines: The Case of Recent Multilateral Negotiations on Public Health, Innovation and Intellectual Property.German Velasquez - 2014 - Developing World Bioethics 14 (2):67-74.
Global health impact: A basis for labeling and licensing campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Intellectual property and global health: from corporate social responsibility to the access to knowledge movement.Cristian Timmermann & Henk van den Belt - 2013 - Liverpool Law Review 34 (1):47-73.
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.
Pharmaceutical companies and access to medicines – social integration and ethical CSR resolution of a global public choice problem.Onyeka K. Osuji & Okechukwu Timothy Umahi - 2012 - Journal of Global Ethics 8 (2-3):139-167.
Asserting The Primacy of Health Over Patent Rights: A Comparative Study of the Processes that Led to the Use of Compulsory Licensing in Thailand and Brazil.Stephanie T. Rosenberg - 2014 - Developing World Bioethics 14 (2):83-91.
Bodies of rights and therapeutic markets.João Biehl & Adriana Petryna - 2011 - Social Research: An International Quarterly 78 (2):359-386.
Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health.Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander - 2012 - Journal of Law, Medicine and Ethics 40 (2):234-250.
The High Price of “Free” Trade: U.S. Trade Agreements and Access to Medicines.Ruth Lopert & Deborah Gleeson - 2013 - Journal of Law, Medicine and Ethics 41 (1):199-223.

Analytics

Added to PP
2015-02-05

Downloads
5 (#1,537,892)

6 months
1 (#1,467,486)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

‘Pharmacy of the World’ is ill?Aman Goyal - 2015 - Developing World Bioethics 15 (1):ii-ii.

Add more citations

References found in this work

Bodies of Rights and Therapeutic Markets.João Biehl & Adriana Petryna - 2011 - Social Research: An International Quarterly 78 (4):359-386.

Add more references